Taken together, these findings indicate that MCPIP1 could serve as a promising biomarker for predicting distant PC metastasis and a target for personalized drug therapy, with the potential to prevent tumor metastasis and improve survival outcomes in patients with cancer. The gene discussed is ZC3H12A; the disease is neoplasm.